Stay updated on Solanezumab vs Placebo in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Solanezumab vs Placebo in Alzheimer's Clinical Trial page.

Latest updates to the Solanezumab vs Placebo in Alzheimer's Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe Sweden location entry has been updated from Malmo, Sweden, 212 24 to Malmö, Sweden, 212 24, correcting the city spelling to include the diacritic and preserving the postal code.SummaryDifference0.0%

- Check18 days agoChange DetectedThis update changes the displayed site software revision from v3.5.2 to v3.5.3, indicating a new build of the page interface/content system rather than a change to the study record itself.SummaryDifference0.0%

- Check26 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision label updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed; this appears to be a minor software update with no changes to study data, eligibility criteria, or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Solanezumab vs Placebo in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Solanezumab vs Placebo in Alzheimer's Clinical Trial page.